ArticleOpen forum infectious diseases2023
Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections.
Sarah Rowe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it